Donor Regulatory T-cells for cGVHD in Patients Who do Not Obtain Complete Remission With Ruxolitinib
Clinical trial NCT05095649 · UNKNOWN
Trial details
- NCT number
- NCT05095649
- Sponsor
- Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-24
- Primary completion
- 2025-08-15
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.